$OKLO

Narayanadas Vivek sold $9K of OKLO

Narayanadas Vivek (General Counsel & Secretary) sold 223 shares of Oklo Inc. (OKLO) at $40.80 on 2026-08-25 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Narayanadas Vivek
Published Aug 27, 2026, 8:34 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 27, 2026, 8:37 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$OKLO
Neutral
high confidence
Mentioned
$OKLO
Relevance
2/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$OKLONeutralLow
01

Why it matters

The disclosed sale is routine and unlikely to affect market perception or price.

02

Market read

Minor insider transaction with negligible trading relevance.

03

What to watch

Potential future insider transactions if the 10b5‑1 plan is part of a larger sell‑down schedule.

Relevance 2/10Novelty 4/10Timing: post‑filing today

Background

Oklo Inc. is a U.S. listed nuclear‑fuel company. Form 4 filings disclose insider trades and are required by the SEC.

Company-level read

Ticker impact

$OKLONeutralHigh confidence
Context

General Counsel sold 223 shares for $9,098 via a 10b5‑1 plan, reducing his holding to 7,599 shares.

Expected impact

No significant price impact expected.

Evidence & confidence

The transaction size is small relative to market cap and disclosed via a Form 4, which is a routine filing.

Market effects

None; the sale does not affect the nuclear energy sector broadly.

None; limited to Oklo shareholders.

None

Counterpoint

The sale could signal insider concern, but the amount is too small to warrant a contrarian trade.

Key entities

  • Narayanadas Vivek

    General Counsel & Secretary of Oklo, reporting a 10b5‑1 sale of 223 shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$OKLOMed

UBS cuts Oklo stock price target to $41 on estimate updates

UBS reduced its price target for Oklo Inc. (NYSE:OKLO) to $41 from $55, citing updated estimates and maintaining a Neutral rating. The stock is down 68% over the past year. Oklo reported a wider-than-expected Q2 2026 loss but exceeded revenue forecasts, with $3.0 billion in cash. The company launched a $1 billion stock offering program. UBS and Truist Securities highlight near-term execution risks and progress in projects.

$OKLOMedAI 8/10

OKLO, XE Stocks Jump After-Hours — Trump Administration Taps Oklo, X-Energy In $200M Push To Power AI Data Centers

Oklo Inc. (OKLO) and X-Energy Inc. (XE) gained in after-hours trading after joining a $200M federal initiative to build nuclear power plants for AI data centers. The program includes Microsoft (MSFT) and Nvidia (NVDA), with $60M allocated to labs and universities. The initiative aims to accelerate reactor construction and reduce staffing needs, addressing rising electricity demand and grid strain.

$OKLOHigh

Nuclear Stocks Oklo, NuScale Power, and X

Shares of Oklo (OKLO), NuScale Power (SMR), and X-Energy (XE) surged after the U.S. House passed the Ratepayer Protection Act, which may boost demand for their small modular reactors as data center power sources. XE stock rose 12.08% to $16.33. Analysts see 106% upside for XE, with a $33.71 average price target.